REATA PHARMACEUTICALS INC Annual Nonoperating Income (Expense) in USD from 2014 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Reata Pharmaceuticals Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2014 to 2022.
  • Reata Pharmaceuticals Inc Nonoperating Income (Expense) for the quarter ending June 30, 2023 was $285M.
  • Reata Pharmaceuticals Inc Nonoperating Income (Expense) for the twelve months ending June 30, 2023 was $265M.
  • Reata Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2022 was -$33.9M, a 36.2% increase from 2021.
  • Reata Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2021 was -$53.1M, a 21% decline from 2020.
  • Reata Pharmaceuticals Inc annual Nonoperating Income (Expense) for 2020 was -$43.9M, a 789% decline from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$33.9M +$19.2M +36.2% Jan 1, 2022 Dec 31, 2022 10-K 2023-02-24
2021 -$53.1M -$9.21M -21% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-24
2020 -$43.9M -$39M -789% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-24
2019 -$4.94M -$1.3M -35.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$3.64M -$2.89M -382% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 -$756K -$970K -453% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-19
2016 $214K +$182K +569% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $32K -$11K -25.6% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-02
2014 $43K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.